Reho P, Kalia V, Jackson G, Wang F, Eiten E, Brennan K
Alzheimers Dement. 2025; 21(3):e70050.
PMID: 40042514
PMC: 11881609.
DOI: 10.1002/alz.70050.
Li D, Yau W, Chen S, Wilton S, Mastaglia F
NPJ Parkinsons Dis. 2025; 11(1):42.
PMID: 40038287
PMC: 11880543.
DOI: 10.1038/s41531-025-00887-3.
Liu W, Lu Y, Liu J, Yu Y, Yang H
Acta Neuropathol Commun. 2025; 13(1):40.
PMID: 39994794
PMC: 11849190.
DOI: 10.1186/s40478-025-01949-6.
Al-Azzani M, Weber S, Ramalingam N, Ramon M, Shvachiy L, Mestre G
medRxiv. 2025; .
PMID: 39990587
PMC: 11844588.
DOI: 10.1101/2025.02.07.25321793.
Qiu T, Li J, Guo Y, Jiang L, Tang J
J Transl Med. 2025; 23(1):221.
PMID: 39987107
PMC: 11846410.
DOI: 10.1186/s12967-025-06213-y.
Carriers of Parkinson's disease-linked SNCA Rep1 variant have greater non-motor decline: a 4 year follow up study.
Santhanakrishnan A, Tan Y, Saffari S, Zhao Y, Ng E, Ng S
Aging (Albany NY). 2025; 17(2):357-364.
PMID: 39907500
PMC: 11892927.
DOI: 10.18632/aging.206196.
The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure.
Hardy J, Escott-Price V
Mol Psychiatry. 2025; .
PMID: 39880902
DOI: 10.1038/s41380-025-02911-7.
The novel p.A30G SNCA pathogenic variant in Greek patients with familial and sporadic Parkinson's disease.
Alefanti I, Koros C, Tsami V, Simitsi A, Kartanou C, Papagiannakis N
Eur J Neurol. 2025; 32(2):e16562.
PMID: 39878395
PMC: 11775907.
DOI: 10.1111/ene.16562.
NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson's model.
Alecu J, Sigutova V, Brazdis R, Lorentz S, Bogiongko M, Nursaitova A
BMC Neurosci. 2025; 26(1):8.
PMID: 39875842
PMC: 11773751.
DOI: 10.1186/s12868-025-00926-y.
Acute lipid droplet accumulation induced by the inhibition of the phospholipase DDHD2 does not affect the level, solubility, or phosphoserine-129 status of α-synuclein.
Bolsinger M, Moors T, Brontesi L, Nuber S, Dettmer U, Ramalingam N
Metab Brain Dis. 2025; 40(1):111.
PMID: 39853540
DOI: 10.1007/s11011-025-01534-9.
Dopaminergic neurodegeneration in cultivated with .
Griffin E, Owens M
MicroPubl Biol. 2025; 2025.
PMID: 39839711
PMC: 11749262.
DOI: 10.17912/micropub.biology.001423.
Pathophysiological Significance of α-Synuclein in Sympathetic Nerves: In Vivo Observations.
Isonaka R, Sullivan P, Goldstein D
Neurology. 2025; 104(3):e210215.
PMID: 39805051
PMC: 11735147.
DOI: 10.1212/WNL.0000000000210215.
The α-Synuclein Seeding Amplification Assay for Parkinson's Disease.
Yi L, Tan E, Zhou Z
Int J Mol Sci. 2025; 26(1.
PMID: 39796243
PMC: 11720040.
DOI: 10.3390/ijms26010389.
Alpha-Synuclein Inhibits the Secretion of Extracellular Vesicles through Disruptions in YKT6 Lipidation.
Tsunemi T, Ishiguro Y, Yoroisaka A, Feng D, Shimada T, Niiyama S
J Neurosci. 2025; 45(11).
PMID: 39794126
PMC: 11905360.
DOI: 10.1523/JNEUROSCI.2350-23.2024.
Long-read sequencing of hundreds of diverse brains provides insight into the impact of structural variation on gene expression and DNA methylation.
Billingsley K, Meredith M, Daida K, Jerez P, Negi S, Malik L
bioRxiv. 2025; .
PMID: 39764002
PMC: 11702628.
DOI: 10.1101/2024.12.16.628723.
Parkinson disease-associated toxic exposures selectively up-regulate vesicular glutamate transporter vGlut2 in a model of human cortical neurons.
Clark K, White A, Paslawski W, Alexander K, Peng S, Young-Pearse T
Mol Biol Cell. 2025; 36(2):br4.
PMID: 39745872
PMC: 11809304.
DOI: 10.1091/mbc.E24-08-0376.
Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health.
Uytterhoeven V, Verstreken P, Nachman E
J Cell Biol. 2024; 224(2).
PMID: 39718548
PMC: 11668179.
DOI: 10.1083/jcb.202409104.
Bacterial products initiation of alpha-synuclein pathology: an in vitro study.
Ioghen O, Gaina G, Lambrescu I, Manole E, Pop S, Niculescu T
Sci Rep. 2024; 14(1):30306.
PMID: 39639092
PMC: 11621565.
DOI: 10.1038/s41598-024-81020-x.
Dysregulation of protein degradation and alteration of secretome in α-synuclein-exposed astrocytes: implications for dopaminergic neuronal dysfunction.
Raj A, Banerjee R, Holla V, Kamble N, Yadav R, Pal P
Cell Commun Signal. 2024; 22(1):574.
PMID: 39617881
PMC: 11610152.
DOI: 10.1186/s12964-024-01928-9.
MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity.
Jensen N, Fu Y, Betzer C, Li H, Elfarrash S, Shaib A
NPJ Parkinsons Dis. 2024; 10(1):227.
PMID: 39613827
PMC: 11607433.
DOI: 10.1038/s41531-024-00841-9.
